Nirmatrelvir / Ritonavir Tablet Suppliers & Bulk Manufacturers
Available Forms: Tablet
Available Strengths: Nirmatrelvir(150 mg) + Ritonavir(100 mg)
Reference Brands: Paxlovid®(US & EU- For Emergency Use Authorization)
Category: Anti Covid Medicines
Paxlovid® (Nirmatrelvir + Ritonavir) is a key oral antiviral for high-risk COVID-19 patients, approved in the US, EU, and many global markets. Each 5-day pack includes Nirmatrelvir 150 mg + Ritonavir 100 mg tablets. PharmaB2B platforms connect buyers with verified suppliers offering Paxlovid and generic versions for bulk procurement, institutional tenders, and international distribution—ensuring regulatory compliance and fast delivery.
Product Description:
Nirmatrelvir + Ritonavir, branded as Paxlovid®, is a leading oral antiviral approved in the US, EU, and globally for treating mild to moderate COVID-19 in high-risk adults. Paxlovid combines Nirmatrelvir 150 mg (2 tablets) with Ritonavir 100 mg (1 tablet), taken twice daily for 5 days. Available in convenient blister packs, it is in high demand for hospitals and COVID-19 programs. Through trusted PharmaB2B platforms, buyers can source Paxlovid or generic equivalents from verified manufacturers, ensuring regulatory compliance, competitive pricing, and global logistics. Partner with reliable suppliers for seamless bulk procurement and international distribution.
Nirmatrelvir / Ritonavir Tablet — third party manufacturing & bulk supply
Nirmatrelvir / Ritonavir Tablet is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:
What to include when you enquire
- Destination market — determines which manufacturers hold the right site-level approvals
- First order quantity and estimated annual volume
- Whether you need a registration dossier or the product is already registered
- Packaging, labelling and language requirements
- Incoterms and required shelf life
Manufacturers of Nirmatrelvir / Ritonavir Tablet listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding. Narcotic drugs and controlled substances are supplied strictly against valid import and export permits issued by the competent authorities.
Request a quote for Nirmatrelvir / Ritonavir Tablet →The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Frequently Asked Questions
Nirmatrelvir / ritonavir is used for the treatment of COVID-19 in adults and pediatric patients at high risk for progression to severe disease. It works by inhibiting viral replication to help reduce the severity and duration of infection.
It is made from the active pharmaceutical ingredients nirmatrelvir, a SARS-CoV-2 protease inhibitor, and ritonavir, which boosts the effectiveness of nirmatrelvir by slowing its metabolism.
It is marketed under the trade name Paxlovid.
Nirmatrelvir / ritonavir (Paxlovid) is manufactured and marketed by Pfizer.
The generic name is nirmatrelvir / ritonavir.
Paxlovid.
It is manufactured in FDA-, EMA-, and MHRA-approved facilities by Pfizer for the USA, EU, UK, and other regulated markets.
Related Products
Baricitinib
Strength:
2 mg, 4 mg
Form: Tablet
Reference Brands: Olumiant®(EU & US- Emergency Use Authorization (EUA)
View Details
Tocilizumab
Strength:
IV: 80 mg/4 mL, 200 mg/10 mL, 400 mg/20 mL; SQ: 162 mg/0.9 mL (pen or syringe)
Form: IV injection, SQ Injection
Reference Brands: Actemra®(US); RoActemra®(EU)
View Details
Favipiravir Tablet
Strength:
200 mg, 400 mg, 600 mg
Form: Tablet
Reference Brands: Fabiflu, Favicovid, Covihalt, Avifavir, Avigan, Favira , Favilow(Globally, Not approved in USA & EU)
View DetailsQuick Response Guaranteed | Verified Suppliers
